🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

100 results for “Pacira” Clear

  1. Methadone

    Pacira Ireland Limited

    Adolescent Idiopathic Scoliosis

    approved small molecule completed

    1 trial

  2. Popliteal nerve block including liposomal bupivacaine

    Pacira Ireland Limited

    Moderate-to-severely Painful Ankle Surgery

    approved small molecule active

    1 trial

  3. morphine sulfate

    Pacira Ireland Limited

    Bowel Obstruction

    approved small molecule terminated

    1 trial

  4. Exparel block in arthroscopic shoulder surgery

    Pacira Ireland Limited

    Injury of Shoulder Region

    small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources